First-In-Class Ruthenium Anticancer Drug (KP1339/IT-139) Induces an Immunogenic Cell Death Signature in Colorectal Spheroids in Vitro
Metallomics - United Kingdom
doi 10.1039/c9mt00051h
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Royal Society of Chemistry (RSC)